These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 16493118)

  • 21. Lack of association between rs1800795 (-174 G/C) polymorphism in the promoter region of interleukin-6 gene and susceptibility to type 2 diabetes in Isfahan population.
    Ghavimi R; Sharifi M; Mohaghegh MA; Mohammadian H; Khadempar S; Rezaei H
    Adv Biomed Res; 2016; 5():18. PubMed ID: 26962520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of IL-6 572 C/G, 190 C/T, and 174 G/C gene polymorphisms in children's obesity.
    Oana MC; Claudia B; Carmen D; Maria PA; Septimiu V; Claudiu M
    Eur J Pediatr; 2014 Oct; 173(10):1285-96. PubMed ID: 24740880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A common variation in the promoter region of interleukin-6 gene shows association with exercise performance.
    Huuskonen A; Tanskanen M; Lappalainen J; Oksala N; Kyröläinen H; Atalay M
    J Sports Sci Med; 2009; 8(2):271-7. PubMed ID: 24149537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress and inflammation interactions in human obesity.
    Bondia-Pons I; Ryan L; Martinez JA
    J Physiol Biochem; 2012 Dec; 68(4):701-11. PubMed ID: 22351038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach.
    Curti ML; Jacob P; Borges MC; Rogero MM; Ferreira SR
    J Obes; 2011; 2011():497401. PubMed ID: 21773006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant -174G>C with circulating glucose levels, interleukin-6 levels, and body mass index.
    Huth C; Illig T; Herder C; Gieger C; Grallert H; Vollmert C; Rathmann W; Hamid YH; Pedersen O; Hansen T; Thorand B; Meisinger C; Doring A; Klopp N; Gohlke H; Lieb W; Hengstenberg C; Lyssenko V; Groop L; Ireland H; Stephens JW; Wernstedt Asterholm I; Jansson JO; Boeing H; Mohlig M; Stringham HM; Boehnke M; Tuomilehto J; Fernandez-Real JM; Lopez-Bermejo A; Gallart L; Vendrell J; Humphries SE; Kronenberg F; Wichmann HE; Heid IM
    Ann Med; 2009; 41(2):128-38. PubMed ID: 18752089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modifying effects of IL-6 polymorphisms on body size-associated breast cancer risk.
    Slattery ML; Curtin K; Sweeney C; Wolff RK; Baumgartner RN; Baumgartner KB; Giuliano AR; Byers T
    Obesity (Silver Spring); 2008 Feb; 16(2):339-47. PubMed ID: 18239642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between IL-6 -174G/C polymorphism and acute rejection of renal allograft: evidence from a meta-analysis.
    Lv R; Hu X; Bai Y; Long H; Xu L; Liu Z; Li X; Huang H; Wang L; Ying B
    Transpl Immunol; 2012 Jan; 26(1):11-8. PubMed ID: 22024650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between -174G>C polymorphism in the IL-6 promoter region and the risk of obesity: A meta-analysis.
    Hu M; Yu Z; Luo D; Zhang H; Li J; Liang F; Chen R
    Medicine (Baltimore); 2018 Aug; 97(33):e11773. PubMed ID: 30113463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of interleukin 6 -174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight.
    Goyenechea E; Parra D; Martínez JA
    Metabolism; 2007 Dec; 56(12):1643-8. PubMed ID: 17998015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RGS2 C1114G polymorphism and body weight gain in hypertensive patients.
    Sartori M; Ceolotto G; Dorigatti F; Mos L; Santonastaso M; Bratti P; Papparella I; Semplicini A; Palatini P;
    Metabolism; 2008 Mar; 57(3):421-7. PubMed ID: 18249218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
    Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
    J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between plasma IL-6, the IL6 -174G>C gene variant and the metabolic syndrome in type 2 diabetes mellitus.
    Stephens JW; Hurel SJ; Lowe GD; Rumley A; Humphries SE
    Mol Genet Metab; 2007 Apr; 90(4):422-8. PubMed ID: 17123852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interleukin 6-174G/C polymorphism is associated with indices of obesity in men.
    Berthier MT; Paradis AM; Tchernof A; Bergeron J; Prud'homme D; Després JP; Vohl MC
    J Hum Genet; 2003; 48(1):14-9. PubMed ID: 12560873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-6 g.-174G>C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study.
    Klipstein-Grobusch K; Möhlig M; Spranger J; Hoffmann K; Rodrigues FU; Sharma AM; Klaus S; Pfeiffer AF; Boeing H
    Obesity (Silver Spring); 2006 Jan; 14(1):14-8. PubMed ID: 16493118
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.